Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Duffy, M.R., Doszpoly, A., Turner, G., Nicklin, S.A. and Baker, A.H. (2016) The relevance of coagulation factor X protection of adenoviruses in human sera. Gene Therapy, 23(7), pp. 592-596. (doi:10.1038/gt.2016.32) (PMID:27014840) (PMCID:PMC4940928)

Ballantyne, M. D. et al. (2016) Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation, 133(21), pp. 2050-2065. (doi:10.1161/circulationaha.115.021019) (PMID:27052414) (PMCID:PMC4872641)

McDonald, R. A. et al. (2015) Reducing in-stent restenosis therapeutic manipulation of miRNA in vascular remodeling and inflammation. Journal of the American College of Cardiology, 65(21), pp. 2314-2327. (doi:10.1016/j.jacc.2015.03.549) (PMID:26022821) (PMCID:PMC4444526)

Duffy, M., Ma, J., Deng, L., Dakin, R. S., Uil, T., Custers, J., Kelly, S. M. , McVey, J. H., Nicklin, S. A. and Baker, A. H. (2015) Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. PLoS Pathogens, 11(2), e1004673. (doi:10.1371/journal.ppat.1004673) (PMID:25658827) (PMCID:PMC4450073)

Denby, L. et al. (2014) MicroRNA-214 antagonism protects against renal fibrosis. Journal of the American Society of Nephrology, 25(1), pp. 65-80. (doi:10.1681/ASN.2013010072)

Duffy, M. R., Parker, A. L., Kalkman, E. R., White, K., Kovalskyy, D., Kelly, S. M. and Baker, A. H. (2013) Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach. Journal of Controlled Release, 170(1), pp. 132-140. (doi:10.1016/j.jconrel.2013.05.007)

McDonald, R. A. et al. (2013) miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. European Heart Journal, 34(22), pp. 1636-1643. (doi:10.1093/eurheartj/eht105)

Bradshaw, A. C. and Baker, A. H. (2013) Gene therapy for cardiovascular disease: perspectives and potential. Vascular Pharmacology, 58(3), pp. 174-181. (doi:10.1016/j.vph.2012.10.008)

White, K. M., Alba, R., Parker, A. L., Wright, A. F., Bradshaw, A. C. , Delles, C. , McDonald, R. A. and Baker, A. H. (2013) Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile. Journal of Cardiothoracic Surgery, 8(183), (doi:10.1186/1749-8090-8-183)

Parker, A.L., White, K.M., Lavery, C.A., Custers, J., Waddington, S.N. and Baker, A.H. (2013) Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction. Gene Therapy, 20(12), pp. 1158-1164. (doi:10.1038/gt.2013.44)

Robinson, H. C. and Baker, A. H. (2012) How do microRNAs affect vascular smooth muscle cell biology? Current Opinion in Lipidology, 23(5), pp. 405-411. (doi:10.1097/MOL.0b013e32835719a1)

McDonald, R. A., Hata, A., MacLean, M. R., Morrell, N. W. and Baker, A. H. (2012) MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovascular Research, 93(4), pp. 594-604. (doi:10.1093/cvr/cvr299)

Duffy, M. R., Parker, A. L., Bradshaw, A. C. and Baker, A. H. (2012) Manipulation of adenovirus interactions with host factors for gene therapy applications. Nanomedicine, 7(2), pp. 271-288. (doi:10.2217/nnm.11.186)

Alba, R., Bradshaw, A.C. , Mestre-Franc├ęs, N., Verdier, J.-M., Henaff, D. and Baker, A.H. (2012) Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus). Gene Therapy, 19(1), pp. 109-113. (doi:10.1038/gt.2011.87)

Alba, R. et al. (2010) Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood, 14(116), pp. 2656-2664. (doi:10.1182/blood-2009-12-260026)

This list was generated on Fri Sep 20 19:39:59 2019 BST.